Radioiodine uptake after monotherapy with potassium iodide in patients with Graves’ disease-Reference-Cited by-同舟云学术

Radioiodine uptake after monotherapy with potassium iodide in patients with Graves’ disease

Published:2023 Issue:5 Volume:70 Page:541-549
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Mikura Kentaro¹,Yoshimura Noh Jaeduk¹,Watanabe Natsuko¹,Aida Azusa¹,Yoshimura Ran¹,Kinoshita Aya¹,Suzuki Ai¹,Suzuki Nami¹,Fukushita Miho¹,Matsumoto Masako¹,Yoshihara Ai¹,Sugino Kiminori²,Ito Koichi²

Affiliation:

1. Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan

2. Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/70/5/70_EJ22-0505/_pdf

Reference41 articles.

1. 1 Soley MN, Foreman N (1949) Radioiodine therapy in Graves’ disease; a review. J Clin Invest 28: 1367–1374.

2. 2 Hertz S, Roberts A (1942) Radioactive iodine as an indicator in thyroid physiology. V. The use of radioactive iodine in the differential diagnosis of two types of Graves’ disease. J Clin Invest 21: 31–32.

3. 3 Saenger EL, Thoma GE, Tompkins EA (1968) Incidence of leukemia following treatment of hyperthyroidism. Preliminiary report of the cooperative thyrotoxicosis therapy follow-up study. JAMA 205: 855–862.

4. 4 Eschmann SM, Thelen MH, Dittmann H, Bares R (2006) Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves’ disease: results of a prospective study. Exp Clin Endocrinol Diabetes 114: 222–226.

5. 5 Wanibe S, Nihei N, Kasahara F, Sano T (1980) Studies on effect of iodide restriction on thyroidal 131I-uptake (author’s transl). Kaku Igaku 17: 1293–1297 (In Japanese).